Women with primary ovarian failure are at increased risk of hypoactive sexual desire disorder (HSDD). Sexual wellbeing in this population warrants routine clinical assessment, and a specific first-line treatment approach applies.
Hypoactive sexual desire disorder (HSDD) is more common in primary ovarian failure, and it is important to routinely enquire about sexual wellbeing and function during clinical review.
First-line management centres on oestrogen replacement as the principal intervention for improving sexual function in this setting. The complete structured protocol — including individualised decision points and clinical considerations — is available in full via the link below.